Phase 4
Completed N=9
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
Source: ClinicalTrials.gov NCT00791323 ↗Enrolled (actual)
9
Serious AEs
0.0%
Results posted
Sep 2011
Primary outcomePrimary: Mean Prostaglandin E2 (PGE2) Aqueous Humor Levels — 1027.4; 1014.7 Picograms per milliliter (pg/ml)
Summary
A pilot study to evaluate the extent of PGE2 inhibition (mean aqueous values) by Ketorolac 0.04% following peripheral iridotomy
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Prostaglandin E2 (PGE2) Aqueous Humor Levels |
1027.4; 1014.7 | — |
Eligibility Criteria
Inclusion Criteria
- Patients scheduled to undergo phakic IOL implantation
Exclusion Criteria
- History of intraocular surgery in the operative eye
Data sourced from ClinicalTrials.gov (NCT00791323). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.